首页> 外国专利> New platinum complexes obtained by reacting platinum compound and amine compound, useful as anticancer agent

New platinum complexes obtained by reacting platinum compound and amine compound, useful as anticancer agent

机译:通过铂化合物和胺化合物反应获得的新型铂配合物,可用作抗癌剂

摘要

Platinum complexes (I) are new. Platinum complexes of formula (R1-Pt(R2)(X)(-O-(CH 2) n-O-W1-Z)(L1)-L2) (I) are new. X : halo; either R1 : R1aNH 2or 2-picoline directly related to the platinum by its nitrogen atom; and R2 : R2aNH 2, where R1 and R2 are cis configuration relative to platinum; or R1 and R2 together with the platinum atom : 5-7 membered ring of formula (A); R1a, R2a : H, 1-6C alkyl, 1-6C alkenyl or 3-8C cycloalkyl; either L1, L2 : halo, where L1 and L2 is in cis position with respect to the platinum; or L1 and L2 together with the platinum : 5-7 membered ring of formula (B), (both the ring (A) and/or (B) are optionally substituted with at least one 4C alkyl, optionally fused by two carbon atoms together with 4-8C cycloalkyl or saturated 4-8C mono or bicyclic heterocycloalkyl, and optionally spiro-substituted with 4-8C cycloalkyl or saturated 4-8C mono or bicyclic heterocycloalkyl); V1 : CH 2, C(O) or P(O)OH; Y1 : a bond or (CR1R2) 1-2; R1, R2 : H or 1-4C alkyl; W1 : single bond, -C(O)-(CH 2) m-NH-C(O)- or -C(O)-(CH 2) mC(O)-NH-group attached to (CH 2) nby the group C(O); n, m : 2-4; and Z : a fragment of a targeting agent attached to W1 may to be recognized by a tumor cell and such that ZH is a bile acid or a polyunsaturated fatty acid (when W1 represents a single bond) and Z-COOH or NH 2is antibody, a peptide, a sugar, a hormone, vitamin, folic acid, biotin, an endogenous or synthetic ligand of a receptor overexpressed on the surface of a tumor cell. An independent claim is included for use of (I) as precursor of platinum compound of formula (R1-Pt(R2)(X)(-O-(CH 2) n-OH)(L1)-L2) (II) and platinum complex of formula (R1-Pt(R2)(L1)-L2) (III). [Image] ACTIVITY : Cytostatic. MECHANISM OF ACTION : None given.
机译:铂络合物(I)是新的。式(R1-Pt(R2)(X)(-O-(CH 2)n-O-W1-Z)(L1)-L2)(I)的铂配合物是新的。 X:晕; R1:R1aNH 2或2-甲基吡啶通过其氮原子直接与铂相关; R2:R2aNH 2,其中R1和R2为相对于铂的顺式构型; R1和R2与铂原子一起:式(A)的5-7元环;或R1a,R2a:H,1-6C烷基,1-6C烯基或3-8C环烷基; L1,L2:卤素,其中L1和L2相对于铂处于顺式位置;或L1和L2与式(B)的铂:5-7元环一起(环(A)和/或(B)两者任选地被至少一个4C烷基取代,任选地被两个碳原子稠合在一起)用4-8C环烷基或饱和的4-8C单环或双环杂环烷基,和任选地被4-8C环烷基或饱和的4-8C单环或双环杂环烷基螺取代); V1:CH 2,C(O)或P(O)OH; Y1:键或(CR1R2)1-2; R1,R2:H或1-4C烷基; W1:单键,-C(O)-(CH 2)m-NH-C(O)-或-C(O)-(CH 2)mC(O)-NH-基团与(CH 2)nby连接C(O)组; n,m:2-4; Z:附着于W1的靶向剂的片段可以被肿瘤细胞识别,ZH为胆汁酸或多不饱和脂肪酸(W1为单键时),Z-COOH或NH 2为抗体,肽,糖,激素,维生素,叶酸,生物素,在肿瘤细胞表面过度表达的受体的内源性或合成配体。包括使用(I)作为式(R1-Pt(R2)(X)(-O-(CH 2)n-OH)(L1)-L2)的铂化合物的前体的独立权利要求,以及式(R1-Pt(R2)(L1)-L2)(III)的铂配合物。 [图像]活动:细胞静止。作用机理:未给出。

著录项

  • 公开/公告号FR2954321A1

    专利类型

  • 公开/公告日2011-06-24

    原文格式PDF

  • 申请/专利权人 SANOFI-AVENTIS;

    申请/专利号FR20100055766

  • 申请日2010-07-15

  • 分类号C07F15;A61K31/555;A61K47/48;A61P35;

  • 国家 FR

  • 入库时间 2022-08-21 17:45:43

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号